Lobbying Income
$220K
Filings
17
Unique Clients
2
Active Period
2024–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Restore Protections for Dialysis Patients Act
2026 · third_quarter · Client: DAVITA, INC.
HR 2199/S 1173, Restore Protections for Dialysis Patients Act. Issues related to access to treatment for End Stage Renal Disease (ESRD).
Client expense: — · Firm income: $20,000
Matched citations: HR 2199
Restore Protections for Dialysis Patients Act
2026 · third_quarter · Client: DAVITA, INC.
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: HR 2199
Restore Protections for Dialysis Patients Act
2026 · third_quarter · Client: DAVITA, INC.
HR 2199/S 1173, Restore Protections for Dialysis Patients Act. Issues related to access to treatment for End Stage Renal Disease (ESRD).
Client expense: — · Firm income: $20,000
Matched citations: S 1173
Restore Protections for Dialysis Patients Act
2026 · third_quarter · Client: DAVITA, INC.
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: S 1173
Restore Protections for Dialysis Patients Act
2026 · second_quarter · Client: DAVITA, INC.
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: HR 2199
Restore Protections for Dialysis Patients Act
2026 · second_quarter · Client: DAVITA, INC.
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: HR 2199
Restore Protections for Dialysis Patients Act
2026 · second_quarter · Client: DAVITA, INC.
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: S 1173
Restore Protections for Dialysis Patients Act
2026 · second_quarter · Client: DAVITA, INC.
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: S 1173
Innovative FEED Act of 2025
2026 · second_quarter · Client: ANZU STRATEGIES (OBO ELANCO US INC)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Client expense: — · Firm income: —
Matched citations: H.R. 2203
Innovative FEED Act of 2025
2026 · second_quarter · Client: ANZU STRATEGIES (OBO ELANCO US INC)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Client expense: — · Firm income: —
Matched citations: H.R. 2203
Innovative FEED Act of 2025
2026 · first_quarter · Client: ANZU STRATEGIES (OBO ELANCO US INC)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2203
Innovative FEED Act of 2025
2026 · first_quarter · Client: ANZU STRATEGIES (OBO ELANCO US INC)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2203
Restore Protections for Dialysis Patients Act
2026 · first_quarter · Client: DAVITA, INC.
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: HR 2199
Restore Protections for Dialysis Patients Act
2026 · first_quarter · Client: DAVITA, INC.
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: HR 2199
Restore Protections for Dialysis Patients Act
2026 · first_quarter · Client: DAVITA, INC.
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: S 1173
Restore Protections for Dialysis Patients Act
2026 · first_quarter · Client: DAVITA, INC.
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: S 1173
Innovative FEED Act of 2025
2025 · fourth_quarter · Client: ANZU STRATEGIES (OBO ELANCO US INC)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2203
Innovative FEED Act of 2025
2025 · fourth_quarter · Client: ANZU STRATEGIES (OBO ELANCO US INC)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2203
Restore Protections for Dialysis Patients Act
2025 · fourth_quarter · Client: DAVITA, INC.
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: HR 2199
Restore Protections for Dialysis Patients Act
2025 · fourth_quarter · Client: DAVITA, INC.
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: HR 2199
Restore Protections for Dialysis Patients Act
2025 · fourth_quarter · Client: DAVITA, INC.
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: S 1173
Restore Protections for Dialysis Patients Act
2025 · fourth_quarter · Client: DAVITA, INC.
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: S 1173
Innovative FEED Act of 2025
2025 · third_quarter · Client: ANZU STRATEGIES (OBO ELANCO US INC)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2203
Innovative FEED Act of 2025
2025 · third_quarter · Client: ANZU STRATEGIES (OBO ELANCO US INC)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2203
Restore Protections for Dialysis Patients Act
2025 · third_quarter · Client: DAVITA, INC.
HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Client expense: — · Firm income: $20,000
Matched citations: HR 2199
Source: Senate LDA